This course has expired. View available courses.

Infectious Disease

High Risk and COVID-19: Protecting Your Patients at Elevated Risk

There are a wide number of conditions and circumstances that increase an individual’s risk of having severe outcomes associated with COVID-19 infection. Some have conditions or take medications that can interfere with the immune response associated with the current COVID-19 vaccine. Healthcare professionals must be able to identify and recommend strategies to reduce the risk of severe outcomes for these patients. This webinar will review some of the factors that increase COVID-19 risk and strategies that can be implemented to reduce the risk.

DURATION

1 hr

PROFESSION

Physician, Nursing, Pharmacy, Allied Health, Medical Resident, Student, Specialist

# OF CREDITS

0

ACCREDITATION

Unaccredited

EXPIRY DATE

2023-08-19

There are a wide number of conditions and circumstances that increase an individual’s risk of having severe outcomes associated with COVID-19 infection. Some have conditions or take medications that can interfere with the immune response associated with the current COVID-19 vaccine. Healthcare professionals must be able to identify and recommend strategies to reduce the risk of severe outcomes for these patients. This webinar will review some of the factors that increase COVID-19 risk and strategies that can be implemented to reduce the risk.


This program has received funding from Moderna.

Faculty

Peter J. Lin, MD, CCFP

Akshay Jain, MD, FRCPC, FACE, CCD, ECNU, DABIM, DABOM

Alan Kaplan, MD, CCFP(EM), FCFP, CPC(HC)

Allison McGeer, Msc, MD, FRCPC

Learning objectives

Upon completion of this continuing education video participants will be better able to:

  • Identify patients in practice at elevated risk of severe COVID-19 outcomes
  • Summarize the different factors that increase the risk of hospitalization and death from a COVID-19 infection
  • Discuss the different vaccine recommendations for patients at elevated risk
  • Recommend strategies to reduce the risk of severe COVID-19 in patients at high risk
Cost of course:  
Free
# of credits: 0
Duration: 1 hr

FAQs & HELP

MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.

All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.

The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.

Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.

MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.

Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.

No, registration with MDBriefCase is free!

To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.

If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.

Please note: if you submitted multiple password resets, only the link on the most recent email is valid.

You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.

High Risk and COVID-19: Protecting Your Patients at Elevated Risk

1 hr

Duration

Physician, Nursing, Pharmacy, Allied Health, Medical Resident, Student, Specialist

Profession

0

# of credits

Learning Objectives

Upon completion of this continuing education video participants will be better able to:

  • Identify patients in practice at elevated risk of severe COVID-19 outcomes
  • Summarize the different factors that increase the risk of hospitalization and death from a COVID-19 infection
  • Discuss the different vaccine recommendations for patients at elevated risk
  • Recommend strategies to reduce the risk of severe COVID-19 in patients at high risk

Unaccredited

ACCREDITATION

Infectious Disease

Learning Category

General

Topic

0

Price

2023-08-19

Expiry Date

CAN-eng

Region/Language

Course Description

There are a wide number of conditions and circumstances that increase an individual’s risk of having severe outcomes associated with COVID-19 infection. Some have conditions or take medications that can interfere with the immune response associated with the current COVID-19 vaccine. Healthcare professionals must be able to identify and recommend strategies to reduce the risk of severe outcomes for these patients. This webinar will review some of the factors that increase COVID-19 risk and strategies that can be implemented to reduce the risk.


This program has received funding from Moderna.

Faculty

Peter J. Lin, MD, CCFP

Akshay Jain, MD, FRCPC, FACE, CCD, ECNU, DABIM, DABOM

Alan Kaplan, MD, CCFP(EM), FCFP, CPC(HC)

Allison McGeer, Msc, MD, FRCPC

Accreditation

Unaccredited